Left Right

HHS Rules Free Cancer Medication Plans Do Not Violate Anti-Kickback Laws

Aug 20, 2015 | | Corporate Governance, Drug policy, Health Law, Law, Legislation, Pharmaceuticals | No Comments

The U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG) recently released an advisory opinion that two drug-makers’ plans to offer free cancer treatments to patients whose insurance coverage has been delayed does not violate the Anti-Kickback Statute. Under the plans, cancer patients that experience a delay in coverage of more than five days could receive two 30-day supplies of the medications at no cost. Influencing a physician’s decision-making through the use of free products could trigger penalties under the Anti-Kickback Statute; however, HHS believes there are sufficient safeguards to prevent fraud and abuse under the arrangements. Read more.

Leave a reply